Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer

NCT02527785 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Stomach Neoplasm

Interventions

DRUG: Oxaliplatin, Irinotecan, S-1(OIS)

Sponsor

Hallym University Medical Center

Collaborators

[object Object]